Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:34
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
Breakthrough Australian Cancer trial: retraining immune cells offers new hope for patients 2024-10-31 12:00
Toshiba and Naturenix Launch Demonstration Test of Battery Subscription Service for Electric Motorcycle Taxis in Bangkok 2024-10-31 12:00
EQT Acquires Leading SaaS Talent Solutions Provider PageUp to Accelerate Global Expansion and Product Innovation 2024-10-31 11:35
Eat Like a Shogun in Saitama-Kawaguchi -November 2024 to January 2025 2024-10-31 11:03
The 2024 Asia Green and Low-Carbon Development Roundtable was held 2024-10-31 10:54
MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024 2024-10-31 10:51
AIKO Showcases its High-Efficiency N-type ABC Modules at All Energy Australia 2024-10-31 10:44
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration 2024-10-31 10:26
TIER IV's AI Pilot system certified for Level 4 autonomous bus service in Nagano Prefecture 2024-10-31 10:23
Regal Hotels Pioneers Green Meetings Elevating Sustainable Practices for MICE Events in Hong Kong 2024-10-31 09:20
The 35kV power grid project has been put into operation and will provide power transmission to support local economic development 2024-10-31 09:20
ANGEL Shines at FHA HoReCa 2024 with Leading Water Purification Solutions 2024-10-31 09:05
Agoda Highlights 7 Ski Destinations for Winter Sport Enthusiasts 2024-10-31 09:00
Hyundai Motor Reveals Bold and Efficient Hydrogen FCEV Concept Previewing New Design Language 2024-10-31 09:00
AXOR Makes a Grand Debut at EICMA 2024, Milan: A Global Stage for Innovation and Rider Safety 2024-10-31 09:00
A bond forged through the fragrance 2024-10-31 09:00
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab 2024-10-31 08:46
CNOOC Limited Announces Mero3 Project Commences Production 2024-10-31 08:18
1 65 66 67 68 69 12031